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doi:10.1016/j.jmii.2011.04.013Background: Group B Streptococcus (GBS) (Streptococcus agalactiae) is an important pathogen
in neonates, pregnant women, and adults with underlying disease.
Methods: Fifty clinical isolates were collected during the period 2001e2004 and analyzed by
multilocus sequence typing and capsular serotyping.
Results: The six major sequence types (STs) identified by multilocus sequence typing were ST1,
ST12, ST19, ST17, ST23, and ST10. Five major clonal complexes (CCs) and one single ST (ST61)
from 11 different STs were found. CC1 (nZ 14) was the most common one, followed by CC12
(nZ 13), CC19 (nZ 9), CC17 (nZ 7), and CC23 (nZ 6). The most common serotypes were
serotype III, followed by Ib, V, Ia, and IV. The most invasive strains in adults belonged to
ST1 (CC1) and serotype V, and those in neonates belonged to ST17 (CC17) and serotype III.
In addition, ST19 was distributed in adults and neonates.
Conclusions: These results are similar to those of previous reports, but some geographic
differences were found, suggesting that limited clonal lineages play important roles in GBS-
associated diseases worldwide. Continued tracking of GBS in the population through clinical
isolates is important for epidemiologic investigations and vaccine development.
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MLST of invasive group B Streptococcus 431Introduction on 5% sheep blood agar plate, gram-positive cocci in pairsGroup B Streptococcus (GBS) (Streptococcus agalactiae) is
a gram-positive, catalase-negative, b-hemolytic microor-
ganism that is an important cause of illness in newborn
infants, pregnant women, and nonpregnant adults with
underlying medical conditions.1e3 In newborns, GBS infec-
tion can lead to early- or late-onset diseases.2 Early-onset
disease, occurring usually within the first few hours to 1
week of life, results from aspiration of contaminated
amniotic fluid. Late-onset disease, occurring between 1
week and 12 weeks of life, is thought to result from GBS
contamination during passage through the birth canal. Both
can present as sepsis, meningitis, bone and soft tissue
infections, and pneumonia. In pregnant women, coloniza-
tion with GBS is a risk factor for premature delivery, and
ascending GBS spread can lead to chorioamnionitis and
maternal sepsis.2 In nonpregnant adults, especially those
with diabetes, cirrhosis, or malignancy, a variety of invasive
diseases, including skin, soft tissue, and osteoarticular
infections; pneumonia; urosepsis; meningitis; and endo-
carditis, can result from GBS infection.1,3
Traditionally, descriptive epidemiology of GBS has relied
on capsular serotyping (Ia, Ib, IIeVIII)4 or genetic typing,
including that determined by pulsed-field gel electropho-
resis,5 multilocus sequence typing (MLST),6 restriction
digestion pattern,7 restriction fragment length pattern,8
and multilocus enzyme electrophoresis typing.9 MLST is an
unambiguous sequence-based typing method that involves
sequencing approximately 500-bp fragments of seven
housekeeping genes. MLST is one of the most reliable
tools for GBS typing, with sufficient discrimination for use
in epidemiology and unambiguous characterization of
isolates.6,10 There are few reports regarding serotyping, in
particular, genotyping, of clinical GBS isolated in Taiwan.
The aim of this study was to determine the serotype and
genotype (by MLST) distributions in Taiwan and their
correlations with clinical disease.
Methods
Collection of clinical isolates
Fifty clinical GBS isolates (33 from adults aged 18 years or
older and 17 from infants aged 12 months or less) were
collected during the period 2001e2004 at China Medical
University Hospital, a medical center in central Taiwan with
more than 2,000 beds. Isolates obtained from sterile sites,
such as blood or body fluid (including cerebrospinal fluid,
ascites, pleural effusion, and pericardial effusion), were
indicated as invasive disease, and those from other sites
were defined as noninvasive disease. Thirty-four strains
were invasive (19 from blood, 13 from cerebrospinal fluid,
and 2 from pleural and pericardial effusions). Sixteen were
noninvasive (7 from cervical swabs of pregnant women, 6
from urine, and 3 from wound discharge).
Identification, serotyping, and MLST of GBS isolates
Isolates on blood agar were identified as GBS by the
following criteria: narrow zone of beta-hemolytic coloniesor short chains, negative reaction with catalase reagent,
positive reaction with Christie/Atkins/MunchePeterson
test, and Lancefield grouping with serotype B antiserum.
Capsular serotyping was classified by a grouping latex
agglutination test (Phadebact Strep B Kit; Boule Diagnostic
AB, Hudding, Sweden) and a coagglutination test (PhathoDx
Strep Grouping Kit; Diagnostic Products Corp., Los Angeles,
CA, USA).
MLSTwas performed as described by Jones et al.6 Initially,
DNA from each isolate was extracted with a DNA isolation kit
(Gentra Systems, Minneapolis, MN, USA). Seven house-
keeping genes used for GBS characterization were amplified
from DNA extracts by polymerase chain reaction, Taq poly-
merase (Applied Biosystems, Foster, CA, USA), and a poly-
merase chain reaction system (ABI 9700; Applied
Biosystems). The seven loci were alcohol dehydrogenase,
phenylalanyl tRNA synthetase, amino acid transporter
protein, glutamine synthetase, L-serine dehydratase,
glucose kinase, and transketolase. The amplicons were
sequenced by ABI Prism BigDye Termination Cycle
Sequencing Ready reaction kit (The Perkin-Elmer Corpora-
tion, Foster City, CA, USA). The sequence of each locus was
then uploaded to the GBS database at http://pubmlst.org/
sagalactiae/to obtain an allele designation. The combina-
tion of alleles at the seven loci was assigned to a unique
sequence type (ST) for each isolate. The genetic relatedness
of the strains was then assessed by cluster analysis with the
unweighted pair group method with arithmetic average
algorithm. The eBURST program (Department of Infectious
Disease Epidemiology of Imperial College London, London)
was used to group isolates into lineages or clonal complexes
(CCs), which share six or seven identical alleles.11 The
eBURST algorithm is implemented at http://eburst.mlst.
net, and detailed user guide is available in this website.
Statistical analysis
Differences between groups were analyzed by the Fisher
exact test, and multivariate analysis was performed with
SAS software, version 9.1 (SAS Institute, Cary, NC, USA). A p
value of 0.05 or less was considered statistically significant,
and all tests of significance were two tailed.
Results
The mean age of the 33 adults was 55.8 years (range, 25e70
years). Among isolates obtained from nonpregnant adults,
73% (19 in 26 strains) were obtained from patients with
malignancy, diabetes, or liver disease. Among the 17
infants, five episodes were early-onset disease and 12
episodes were late-onset disease. The characteristics of
GBS isolates according to ST and serotype are listed in
Table 1. The sequences of the seven MLST loci were
determined for the 50 strains, and allelic profiles were
assigned. The 50 isolates were resolved into 11 STs. A total
of 90% of all isolates were composed of six major STs: ST1
(26%), ST12 (16%), ST19 (16%), ST17 (12%), ST23 (12%), and
ST10 (8%). There was only one isolate each for five
uncommon STs (ST3, ST16, ST106, ST139, and ST188).
Among the six common STs, more frequent invasive
Table 1 Characteristics of group B Streptococcus isolates according to ST and CC
CC (numbers)
and ST
Allelic profilea Serotypes
(no. of isolates)
No. of isolates
(adult, neonatalb)
Invasive no.
(adult, neonatalb)
Noninvasive no.
(adult, neonatalb)
CC1 (14)
1 1,1,2,1,1,2,2 V (8), VI (2), NT (2), Ib (1) 13 (12, 1) 10 (9, 1) 3 (3, 0)
139 1,1,4,1,1,2,2 V (1) 1 (1, 0) 1 (1, 0) 0
CC19 (9)
19 1,1,3,2,2,2,2 III (5), IV (3) 8 (6, 2) 3 (1, 2) 5 (5, 0)
106 1,1,3,4,1,5,1 III (1) 1 (0, 1) 1 (0, 1) 0
CC12 (13)
12 10,1,4,1,3,3,2 Ib (8) 8 (6, 2) 7 (5, 2) 1 (1, 0)
10 9,1,4,1,3,3,2 II (2), NT (2) 4 (4, 0) 0 4 (4, 0)
3 1,1,4,1,3,3,2 Ib (1) 1 (1, 0) 0 1 (1, 0)
CC17 (7)
17 2,1,1,2,1,1,1 III (5), IV (1) 6 (0, 6) 6 (0, 6) 0
188 2,1,1,2,1,1,2 III (1) 1 (0, 1) 1 (0, 1) 0
CC23 (6)
23 5,4,6,3,21,1,3 Ia (6) 6 (2, 4) 5 (1, 4) 1 (1, 0)
Singleton (1)
61 13,1,6,4,1,1,1 NT (1) 1 (1, 0) 0 1 (1, 0)
Total 50 50 (33, 17) 34 (17, 17) 16 (16, 0)
a The allelic profiles are presented in the following order: adhP, pheS, atr, glnA, sdhA, glcK, and tkt.
b Up to 3 months old.
CCZ clonal complex; NTZ nontypable; STZ sequence type.
Figure 1. Unweighted pair group method with arithmetic
average dendrogram showing the genetic relationship among
the 11 sequence typings (ST) of 50 isolates. The allelic profile
of each ST is shown in parentheses. eBURST analysis identified
five clonal complexes (CCs) by sharing six or seven identical
alleles. )The ancestral genotype of the four groups (1, 12, 19,
and 17).
432 N. Tien et al.episodes were found for ST1 (10 of 13, 77%); ST12 (7 of 8,
87.5%); ST17 (6 of 6, 100%); and ST23 (5 of 6, 83%),
compared with the mean invasive rate for all isolates (34 of
50, 68%). The most invasive ST1 and ST12 isolates (90% and
71%, respectively) were from adults; invasive isolates of
ST17 and ST23 (100% and 80%, respectively) were always of
neonatal origin.
The eBURST analysis revealed five major CCs and one
single ST (ST61, nZ 1) from 11 different STs. The most
common one was CC1 (nZ 14), followed by CC12 (nZ 13),
CC19 (nZ 9), CC17 (nZ 7), and CC23 (nZ 6) (Table 1). CC1
consisted of ST1 and ST139; CC12 consisted of ST3, ST10,
and ST12; CC19 consisted of ST19 and ST106; CC17 con-
sisted of ST17 and ST188; and CC23 consisted of ST23. Most
GBS isolates from CC1, CC19, CC17, and CC23 possessed
a single ST (ST1, ST19, ST17, and ST23, respectively).
Among adult isolates, there were significantly more from
CC1 and CC12 compared with the remaining CCs (odds
ratioZ 12.44; pZ 0.0003). Multivariate logistic analysis
also resulted in an odds ratio of 29.63 and p< 0.0001.
Stratification of adult and neonatal values resulted in an
odds ratio of 5.83 for CC1 or CC12 as adult invasive isolates
(pZ 0.0570). Among neonates, there were significantly
more isolates from CC17 and CC23 than from the remaining
CCs (p< 0.0001).
Among various CCs, the most invasive isolates were
found in CC1 (78.6%), CC17 (100%), and CC23 (83.3%). Most
of the invasive cases of CC17 and CC23 (100% and 80%,
respectively) were from neonates and those of CC1 (91%)
were always from adults. Unweighted pair group method
with arithmetic average was used to constructa dendrogram from the matrix of pairwise allelic differ-
ences between the 11 STs of the 50 isolates (Fig. 1).
Capsular serotype was determined for all isolates. The
most common was serotype III (12 strains), followed by
serotypes Ib (10 strains), V (9 strains), Ia (6 strains), IV (4
strains), II (2 strains), and VI (2 strains). The other five
isolates were nontypable. No isolate of serotype VII or VIII
was identified. Two of the six common STs corresponded to
a single serotype: all ST12 and ST23 serotypes were of
MLST of invasive group B Streptococcus 433serotypes Ib and Ia, respectively. The invasive rates among
serotypes with more than five isolates (serotypes Ia, Ib, III,
and V) were 83%, 80%, 75%, and 88%, respectively, more
than the average invasive rate of all isolates (68%). Most of
the invasive cases among serotypes Ib and V (62.5% and
100%, respectively) were from adults; invasive isolates of
serotypes Ia and III (80% and 89%, respectively) were always
of neonatal origin. Most of the serotype isolates Ia, Ib, and
V (n> 2) were each confined to single CCs: 100% of serotype
Ia GBS was in CC23, 90% of serotype Ib GBS was in CC12, and
100% of serotype V GBS was in CC1. All isolates of serotype
Ia corresponded to one ST (ST23), but other serotypes with
more than two isolates corresponded to two to four STs.Discussion
GBS infection is an important cause of neonatal disease,
and the use of antibiotic prophylaxis after the onset of
labor or rupture of the membranes is highly effective,
especially for high-risk groups, such as those with GBS
colonization, preterm labor, or membrane ruptures.2 In
adults, invasive GBS disease has increased, especially
among those with underlying disease, such as malignancy,
diabetes, or liver disease.1,3 In the present study, 43 of the
50 isolates were from neonates (nZ 17), cervical swabs of
pregnant women (nZ 7), and adults with underlying
disease (nZ 19).
This is the first report of MLST of invasive GBS in Taiwan.
In the present study, the common STs were ST1 (26%), ST12
(16%), ST19 (16%), ST17 (12%), and ST23 (12%). These five
STs are similar to those reported in previous studies, but
there were differences in order.6,12 In respect to the inva-
sive nature, the most invasive was ST1 (29.4%), followed by
ST12 (20.6%), ST17 (17.6%), and ST23 (14.7%) in the present
study. These results differed from reports from Sweden, in
which the common STs from invasive strains were ST17,
ST19, ST23, and ST1 (or ST9).13 However, the predominant
STs are similar. The similar predominant STs and genetic
lineages among different countries suggest that most GBS-
associated diseases are caused by certain clonal lineages,
and that small geographic difference also occurs. All six
ST17 isolates in our study have come from invasive neonatal
diseases, similar to those of other regions, where most ST17
strains were invasive in neonates.6,13 Similarity was also
found in ST19 strains, which were distributed in adults and
neonates.13 However, in the present study, geographic
differences were found for ST23 and ST1, with most arising
from neonates and adults, respectively.6,13
The capsular polysaccharide of GBS is a major virulence
factor for invasive disease, which is divided into nine
serotypes (Ia, Ib, IIeVIII).14 The polysaccharide capsule of
GBS is determined by genes in the CPS locus, which encode
enzymes for polysaccharide synthesis.15,16 No isolate of
serotype VII or VIII was found among our strains. The most
common and most invasive strain was serotype III (24%), as
was reported in other studies in Taiwan and in other
countries.6,13,17 Strains of serotype III were equally divided
into ST17 and ST19 (or CC17 and CC19). Most isolates of
serotypes Ia, Ib, and V corresponded to ST23, ST12, and ST1
(or CC23, CC12, and CC1), respectively, and most strains of
ST1, ST17, ST19, and ST23 expressed capsular serotypes V,III, and Ia, respectively. These distributions were similar to
those of other reports.6,12,13,18 Serotype V GBS emerged in
the 1990s and has become important in terms of clinical
GBS disease, especially in nonpregnant adults.1,19,20 Sero-
type V of GBS is suspected to have undergone clonal spread
in several countries because all isolates belong to CC1 in
our study and in other studies.12,13 Most invasive diseases
(septicemia or meningitis) in neonates are caused by
serotype III GBS (47%),13,17,18 followed by serotype Ia
(23.5%). This result corresponds to the most prevalent
maternal colonization serotypes III and Ia, but not V, in
a previous study.21 Most GBS invasive strains in adults are
serotypes Ia (23e31%), Ib (6e13%), II (8e13%), III (19e21%),
and V (24e31%), according to previous reports, but those
among our present isolates were serotypes V (47%) and Ib
(29.4%).1,19 The transition of invasive strains from serotype
III in neonates to serotype V or other in adults might be
driven by the host immune response or allelic exchange by
horizontal transfer or recombination.13 In addition, several
epidemiologic investigations have shown changes of GBS
serotype distribution over time and in different coun-
tries.1,13,19,20 This might reflect differences in serotype
fitness, herd immunity changes, or the spread of antibiotic-
resistant clones, and is important with respect to vaccine
development.13,14 The shift of clinical serotype distribution
to nonvaccine types in response to the introduction of
pneumococcal vaccination of susceptible populations has
been well documented.22
Overall, each serotype usually contains several different
lineages, and each lineage is also composed of several
serotypes. This indicates that serotype alone is not suffi-
cient for phylogenetic lineage differentiation and that
horizontal transfer of CPS genes, resulting in serotype
switches, occurs within the same lineages.12,13 In addition,
GBS in the same ST but with different serotypes could be
genetically divergent.23 This could explain the divergent
relations between serotypes and clinical presentations
among different CCs. In CC17, most isolates were serotype
III and from invasive neonatal diseases. In CC1, most strains
were from invasive adult conditions but distributed in
different serotypes. In our present study, isolates from
adults were significantly from CC1 or CC12, all isolates of
CC17 were from neonates, and CC19 and CC23 contained
both adult and neonatal isolates. There was a trend for
isolates of CC1 or CC12 to become more invasive in adult
patients, but this did not reach statistical significance
(pZ 0.057), which might be because of fewer case
numbers. These findings suggest that CC19 and CC23 are
successful clones in both adults and neonates, whereas CC1
and CC12, and CC17 appear to be adapted to adults and
neonates, respectively. These variations might reflect
differences in several factors, such as the expression of
adhesins and other virulence factors or host factors.13 For
example, GBS in CC17 with serotype III, corresponding to
restriction digest pattern analysis III-3,6 has been confirmed
to have a higher production of sialic acid and possesses
SPB1, which encodes a protein involved in epithelial cell
invasion.24 This strain has also been demonstrated to be
more virulent than other serotype III GBS strains.25
However, information regarding virulence among different
CCs is presently inadequate for the clarification of various
clinical presentations and requires further study.
434 N. Tien et al.There were several limitations in our study. First, the
collected strain number was relatively small. Second, only
one phenotypic typing (serotyping) and genotyping (MLST)
were applied. Despite the small number of isolates in the
present study, these results are the first regarding GBS
genotyping in Taiwan. Similar results between our study
and other reports indicate that relatively small numbers of
GBS lineages are responsible for human disease or coloni-
zation. However, some differences between our results and
those of others were found. These differences might arise
from geographic variance or inadequate GBS study number
in the present study. Further comparative genetic studies
of clinical significance will be essential for the elucidation
of host tropism and evolution of GBS isolates, as well as for
vaccine development.
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